Emtricitabine

Emtricitabine (CAS 143491-57-0) is a synthetic nucleoside analogue supplied as a pharmaceutical-grade active ingredient. It is commercially known under the trade names Emtriva and 524W91, and abbreviated as FTC or (-)-FTC. No E-code designation applies to this substance.

In pharmaceutical manufacturing, emtricitabine functions as an antiviral agent by inhibiting reverse transcriptase, blocking viral RNA replication at the enzymatic level. It is incorporated into antiretroviral drug formulations targeting HIV and hepatitis B. Secondary applications in personal care research explore its antimicrobial and skin-conditioning activity in preservation systems.

Emtricitabine is available in pharmaceutical-grade crystalline solid form, manufactured in compliance with Ph.Eur. and ICH Q7 GMP guidelines for active pharmaceutical ingredients. It falls under HS code 2934990002 and is subject to REACH registration requirements within the EU. Packaging is supplied according to customer specification and regulatory handling requirements.